Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
86.21%
↑ 1732% above average
Average (9y)
-5.28%
Historical baseline
Range
High:86.21%
Low:-109.61%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 86.21% |
| 2023 | 53.12% |
| 2022 | 60.74% |
| 2021 | -82.31% |
| 2020 | -50.50% |
| 2019 | 46.68% |
| 2018 | -8.02% |
| 2017 | -109.61% |
| 2016 | -47.35% |
| 2015 | -1.80% |